• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Trials >Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'
【24h】

Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'

机译：高影响因子医学期刊认可CONSORT声明：期刊编辑和期刊“作者须知”调查

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background The CONSORT Statement provides recommendations for reporting randomized controlled trials. We assessed the extent to which leading medical journals that publish reports of randomized trials incorporate the CONSORT recommendations into their journal and editorial processes. Methods This article reports on two observational studies. Study 1: We examined the online version of 'Instructions to Authors' for 165 high impact factor medical journals and extracted all text mentioning the CONSORT Statement or CONSORT extension papers. Any mention of the International Committee of Medical Journal Editors (ICMJE) or clinical trial registration were also sought and extracted. Study 2: We surveyed the editor-in-chief, or editorial office, for each of the 165 journals about their journal's endorsement of CONSORT recommendations and its incorporation into their editorial and peer-review processes. Results Study 1: Thirty-eight percent (62/165) of journals mentioned the CONSORT Statement in their online 'Instructions to Authors'; of these 37% (23/62) stated this was a requirement, 63% (39/62) were less clear in their recommendations. Very few journals mentioned the CONSORT extension papers. Journals that referred to CONSORT were more likely to refer to ICMJE guidelines (RR 2.16; 95% CI 1.51 to 3.08) and clinical trial registration (RR 3.67; 95% CI 2.36 to 5.71) than those journals which did not. Study 2: Thirty-nine percent (64/165) of journals responded to the on-line survey, the majority were journal editors. Eighty-eight percent (50/57) of journals recommended authors comply with the CONSORT Statement; 62% (35/56) said they would require this. Forty-one percent (22/53) reported incorporating CONSORT into their peer-review process and 47% (25/53) into their editorial process. Eighty-one percent (47/58) reported including CONSORT in their 'Instructions to Authors' although there was some inconsistency when cross checking information on the journal's website. Sixty-nine percent (31/45) of journals recommended authors comply with the CONSORT extension for cluster trials, 60% (27/45) for harms and 42% (19/45) for non-inferiority and equivalence trials. Few journals mentioned these extensions in their 'Instructions to Authors'. Conclusion Journals should be more explicit in their recommendations and expectations of authors regarding the CONSORT Statement and related CONSORT extensions papers.
机译：背景CONSORT声明为报告随机对照试验提供了建议。我们评估了发表随机试验报告的领先医学期刊在何种程度上将CONSORT建议纳入其期刊和编辑流程。方法本文报道了两项观察性研究。研究1：我们检查了165种高影响因子医学期刊的“作者说明”在线版本，并提取了所有提及CONSORT声明或CONSORT扩展论文的文本。还寻求并提取了国际医学期刊编辑委员会（ICMJE）的任何提及或临床试验注册。研究2：我们针对165种期刊中的每一种，对总编辑或编辑部进行了调查，以了解其期刊对CONSORT建议的认可以及将其纳入其编辑和同行评审过程中的情况。结果研究1：38％（62/165）的期刊在其在线“作者须知”中提到CONSORT声明;在这37％（23/62）中，这是一项要求，而63％（39/62）中的建议不够明确。很少有期刊提到CONSORT扩展论文。与未引用CONSORT的期刊相比，引用CONSORT的期刊更有可能参考ICMJE指南（RR 2.16; 95％CI 1.51至3.08）和临床试验注册（RR 3.67; 95％CI 2.36至5.71）。研究2：有39％（64/165）的期刊对在线调查做出了回应，大多数是期刊编辑。推荐作者中有88％（50/57）的期刊符合CONSORT声明; 62％（35/56）表示他们会要求这样做。有41％（22/53）的人报告将CONSORT纳入其同行评审过程，有47％（25/53）的人将其纳入编辑过程。 81％（47/58）报告将CONSORT包括在其“作者须知”中，尽管在交叉检查期刊网站上的信息时存在一些不一致之处。推荐的作者中有69％（31/45）的期刊符合CONSORT扩展要求进行聚类试验，60％（27/45）适用于危害性试验，42％（19/45）适用于非自卑和对等试验。很少有期刊在“作者说明”中提到这些扩展。结论对于CONSORT声明和相关的CONSORT扩展论文，期刊在作者的建议和期望方面应更加明确。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号